Visual and anatomical outcomes for 2 years
Overall | 2010–2012 | 2011–2013 | 2012–2014 | 2013–2015 | 2014–2016 | 2015–2017 | P value for ANOVA | P value for trend test | |
Baseline BCVA (logMAR) | 0.44±0.37 | 0.46±0.33 | 0.51±0.41 | 0.44±0.35 | 0.44±0.36 | 0.40±0.35 | 0.43±0.38 | 0.003 | 0.002 |
Good/poor (eyes) | 735/1314 | 38/98 | 82/203 | 129/236 | 195/356 | 198/270 | 93/151 | 0.002 | <0.001 |
Final BCVA (logMAR) | 0.40±0.42 | 0.49±0.39 | 0.45±0.44 | 0.44±0.43 | 0.41±0.48 | 0.33±0.35 | 0.30±0.36 | <0.001 | <0.001 |
Good/poor (eyes) | 949/1100 | 48/88 | 119/166 | 140/225 | 256/295 | 242/226 | 144/100 | <0.001 | <0.001 |
Difference of BCVA | −0.04±0.40 | 0.03±0.41 | −0.06±0.38 | 0.00±0.43 | −0.03±0.45 | −0.07±0.34 | −0.13±0.31 | <0.001 | <0.001 |
P value | <0.001 | 0.3527 | 0.0055 | 0.9523 | 0.1107 | <0.001 | <0.001 | – | – |
95% CI (logMAR) | −0.0622 to −0.0278 | −0.0372 to 0.1035 | −0.1078 to −0.0188 | −0.0427 to 0.0454 | −0.0680 to 0.0070 | −0.0978 to −0.0361 | −0.1658 to −0.0884 | – | – |
Baseline CMT (μm) | 443.8±154.8 | 435.7±165.8 | 447.3±155.9 | 456.1±158.1 | 446.1±161.1 | 441.1±151.5 | 425.9±131.8 | 0.279 | 0.180 |
Final CMT (μm) | 335.6±139.6 | 347.9±158.3 | 335.5±134.4 | 354.0±151.8 | 327.3±149.3 | 331.3±130.4 | 328.9±104.6 | 0.070 | 0.059 |
Difference of CMT (μm) | −108.2±186.8 | −87.8±213.6 | −111.8±192.1 | −102.1±198.9 | −118.8±186.2 | −109.8±183.5 | −97.1±150.7 | 0.456 | 0.766 |
P value | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | – | – |
95% CI (logMAR) | −116.3 to −100.0 | −124.9 to −50.7 | −134.7 to −88.9 | −122.7 to −81.5 | −134.5 to −103.1 | −126.5 to −93.1 | −116.1 to −78.0 | – | – |
Data were presented as mean value ±SD.
ANOVA, analysis of variance; BCVA, best corrected visual acuity; CMT, central macular thickness.